Evidence map›Paper›PMID 19023021›Full record

ArticleJournal of applied physiology (Bethesda, Md. : 1985)2009

Hyperbaric oxygen stimulates vasculogenic stem cell growth and differentiation in vivo.

Tatyana N Milovanova, Veena M Bhopale, Elena M Sorokina, Jonni S Moore, Thomas K Hunt, Martin Hauer-Jensen, Omaida C Velazquez, Stephen R Thom

Abstract read
In one paragraph

Article in Journal of applied physiology (Bethesda, Md. : 1985), 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 71 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

71 citing papers in PubMed, 1 synthesis or guideline pooled it, 133 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Tatyana N MilovanovaInstitute for Environmental Medicine, University of Pennsylvania, Philadelphia, PA 19104-6068, USA.
Veena M Bhopale
Elena M Sorokina
Jonni S Moore
Thomas K Hunt
Martin Hauer-Jensen
Omaida C Velazquez
Stephen R Thom
University City Science Center · US

Funding

Recruiting activated endothellal progenitor cells to wounds by hyperoxia & SDF-1aR01GM081570 · NIGMS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI VELAZQUEZ, OMAIDA C · 2008 to 2011
$1.1M
Stem Cell Mobilization in DiabetesR21DK080376 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI THOM, STEPHEN RAYMOND · 2008 to 2009
$433k
NIDDK NIH HHS DK080376NIDDK NIH HHS R21 DK080376NIGMS NIH HHS GM081570NIGMS NIH HHS R01 GM081570
6 · The paper itself

Abstract

We hypothesized that oxidative stress from hyperbaric oxygen (HBO(2), 2.8 ATA for 90 min daily) exerts a trophic effect on vasculogenic stem cells. In a mouse model, circulating stem/progenitor cell (SPC) recruitment and differentiation in subcutaneous Matrigel were stimulated by HBO(2) and by a physiological oxidative stressor, lactate. In combination, HBO(2) and lactate had additive effects. Vascular channels lined by CD34(+) SPCs were identified. HBO(2) and lactate accelerated channel development, cell differentiation based on surface marker expression, and cell cycle entry. CD34(+) SPCs exhibited increases in thioredoxin-1 (Trx1), Trx reductase, hypoxia-inducible factors (HIF)-1, -2, and -3, phosphorylated mitogen-activated protein kinases, vascular endothelial growth factor, and stromal cell-derived factor-1. Cell recruitment to Matrigel and protein synthesis responses were abrogated by N-acetyl cysteine, dithioerythritol, oxamate, apocynin, U-0126, neutralizing anti-vascular endothelial growth factor, or anti-stromal cell-derived factor-1 antibodies, and small inhibitory RNA to Trx reductase, lactate dehydrogenase, gp91(phox), HIF-1 or -2, and in mice conditionally null for HIF-1 in myeloid cells. By causing an oxidative stress, HBO(2) activates a physiological redox-active autocrine loop in SPCs that stimulates vasculogenesis. Thioredoxin system activation leads to elevations in HIF-1 and -2, followed by synthesis of HIF-dependent growth factors. HIF-3 has a negative impact on SPCs.

Indexed as

Cell DifferentiationCell ProliferationHyperbaric OxygenationNeovascularization, PhysiologicOxidative StressAngiogenesis Modulating AgentsAngiogenic ProteinsAnimalsAntioxidantsAutocrine CommunicationBiomarkersBlood VesselsBone Marrow CellsCell CycleCell MovementCollagenAngiogenesis Modulating AgentsAngiogenic ProteinsAntioxidantsBiomarkersCollagenDrug CombinationsGlutathioneHypoxia-Inducible Factor 1Lactic AcidLamininmatrigelProteoglycansReactive Oxygen SpeciesRNA, Small InterferingThioredoxins

Identifiers

PMID19023021
PMCPMC2644249
OpenAlexW2153747264

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.